| a-CGH | array comparative genomic hybridization |
| ASD | autism spectrum disorder |
| MRI | magnetic resonance imaging |
| MDT | multi-disciplinary team |
| EEG | electroencephalogram |
| ADOS | Autism Diagnostic Observation Schedule |
| ADI-R | Autism Diagnostic Interview-Revised (ADI-R) |
| DSM 5TR | Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision |
| MSEL | Mullen Scales of Early Learning (MSEL) |
| CDI | MacArthur–Bates Communicative Developmental Inventory |
| WHO | World Health Organization |
| CDC | Centers for Disease Control and Prevention (CDC) |
| mTOR | mammalian target of rapamycin |
| MECP2 | methyl-CpG-binding protein 2 |
| CNS | central nervous system (CNS) |
| GI | gastrointestinal tract |
| SITBS | self-injurious thoughts and behaviors |
| C-SSRS | Columbia-Suicide Severity Rating Scale |
| ADHD | attention-deficit/hyperactivity disorder |
| IDD | intellectual developmental disorder |
| IQ | intelligence quotient |
| PI3K | phosphoinositide 3-kinases |
| NRXN | neurexins |
| NLGN | neuroligin |
| OCD | obsessive-compulsive disorder |
| FXS | Fragile X syndrome |
| DS | Down syndrome |
| NF1 | neurofibromatosis type I |
| TSC | tuberous sclerosis complex |
| CPK | creatine phosphokinase |
| ED | emergency department |
| SIB | self-injurious behavior |
| NaSSA | noradrenergic and specific serotonergic antidepressants |
| SSRIs | selective serotonin reuptake inhibitors |
| ILAE | International League Against Epilepsy (ILAE) |
| GGE | genetic generalized epilepsy |
| FE | focal epilepsy (FE) |
| FMTLE | mesial temporal lobe epilepsy |
| ADLTE | autosomal dominant lateral temporal epilepsy |
| ADNFLE | autosomal dominant nocturnal frontal lobe epilepsy |
| HS | hippocampal sclerosis |
| FS | febrile seizures |
| LGI1 | leucine-rich glioma-inactivated 1 (LGI1) |
| nAChR | neuronal nicotinic acetylcholine receptor |
| LMICs | middle-income countries |
| HIV | human immunodeficiency virus |
| BBB | Blood–brain barrier |
| GABA | gamma-aminobutyric acid, γ-aminobutyric acid |
| NMDA-R | N-methyl-D-aspartate receptor |
| AMPA | α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid |
| mGLuR5 | metabotropic glutamate receptor 5 (mGluR5), |
| GAD65 | glutamic acid decarboxylase 65 (GAD65), |
| ANNA-1 | antineuronal nuclear antibody type 1 (ANNA-1), |
| IL-1R/TLR | IL-1 receptor/toll-like receptor |
| PAMP | pathogen-associated molecular patterns |
| DAMPs | damage-associated molecular patterns |
| COX2 | cyclooxygenase-2 |
| TGF-β/Smad | transforming growth factor-β/small mothers against decapentaplegic |
| HMGB1 | high-mobility group box-1 (HMGB1) |
| SUDEP | sudden death in wpilepsy |
| SCN1A | sodium voltage-gated channel alpha subunit 1 |
| GABA | 4-aminobutanoic acid |
| CT | computed tomography |
| SPECT | single-photon emission computed tomography |
| SIADH | syndrome of inappropriate secretion of antidiuretic hormone |
| CBZ | carbamazepine |
| CRMP2 | collapsing response mediator protein 2 |
| SV2A | synaptic vesicle glycoprotein 2A |
| AED | antiepileptic drugs |
| RTT | Rett syndrome |
| UBE3A | ubiquitin-protein ligase E3A (UBE3A, |
| ACC | agenesis of the corpus callosum |
| SHANk3 | multiple ankyrin repeat domains 3 |
| ARX | aristaless-related homeobox |
| FOXP2 | forkhead box P2 |
| SCN1A | sodium voltage-gated channel alpha aubunit 1 |
| SCN2A | sodium voltage-gated channel alpha subunit 2 |
| SCN8A | sodium voltage-gated channel alpha subunit 8 |
| KCNB1 | potassium voltage-gated channel subfamily B member 1 |
| CACNA1A | calcium voltage-gated channel subunit alpha1 A |
| SHANK3 | SH3 and multiple ankyrin repeat domains 3 |
| CDKL5 | cyclin-dependent kinase-like 5 |
| STXBP1 | syntaxin binding protein 1 |
| NRXN1 | neurexin 1 |
| PCDH19 | protocadherin 19 |
| CASK | calcium/calmodulin-dependent serine protein kinase |
| SYNGAP1 | synaptic Ras GTPase activating protein 1 |
| YWHAG | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma |
| PACS2 | hosphofurin acidic cluster sorting protein 2 |
| ACTL6B | actin like 6B |
| MEF2C | myocyte enhancer factor 2C |
| FOXG1 | forkhead box G1 |
| VAP | valproic acid |
| TCAs | tricyclic antidepressants (TCAs) |
| EKG | electrocardiogram |
| KS | Klinefelter syndrome |
| ADEM | acute disseminated encephalomyelitis |